Heavy alcohol use has numerous negative impacts on cognition. In many
cases, it appears that excess drinking influences working memory,
problem solving, attention, patterns of regional brain activation, and
even gray and white matter volume. Due to these effects, most
significant conclusions related to cognitive decline are limited to the
assumption that "more is worse." However, heavy alcohol use is a very
complex psychosocial behavior and is subject to a problematic number of
variables. As a result, it is very difficult to extend generalizations
about drinking-related consequences to the overall population since many
environmental and biological differences come into play for every
individual. Three of these variables shown to have significant impact on
cognitive sensitivity to alcohol are age of first alcohol use (age of
drinking initiation), specific pattern of alcohol consumption and
gender. Potential insight can be gained into how individual drinking
scenarios differ in risk for cognitive decline by assessing how each of
these important factors influences cognition independently. Although
some overlap exists between categories, each still appears to contribute
unique influence on likelihood and presentation of cognition-related
effects. Based on existing and current research, age and gender tend to
augment baseline sensitivity to alcohol, with patterns of alcohol intake
also influencing how changes appear. Given these categorical
differences, it is important to consider personal alcohol drinking
history rather than just aggregate alcohol intake as risk factors in the
cognitive impacts of drinking. The objective of this brief review is to
examine the role of these factors on the effect of alcohol on
cognition.
The developments in Human Medical Science and Research in Treatment, Diagnosis, Prevention, Cure and awareness in ADHD, Alcohol and Drugs, Alzheimer disease, Dementia, Depression and Hypertension, Arthritis, Rheumatology, Asthma, Blood and Hematology, Bird Flu Avian Flu and Swine flu, SARS, Bones and Orthopaedics, Body Pain and Back Pain, Crohn’s, Endocrinology, Head Ache and Migraine, Cystic Fibrosis, COPD, Dermatology, Dyslexia, Gynecology and Human Genetics.
Subscribe to:
Post Comments (Atom)
Popular Posts
-
Scientists at Aberdeen's Rowett Research Institute have shown that a high protein, low carbohydrate diet is most effective at reducing...
-
Phase III study presented at American Psychiatric Association Meeting Shire Pharmaceuticals Group plc (NASDAQ: SHPGY, LSE: SHP.L, TSE: SHQ...
-
ADHD - FDA expands indication for ADDERALL XR(R) (CII) confirming safety and efficacy in adolescentsShire Pharmaceuticals Group plc announced today that the US Food and Drug Administration (FDA) has approved ADDERALL XR(R) (mixed salts o...
-
Data from two clinical studies presented at the American Society of Hypertension's Twentieth Annual Scientific Meeting (ASH 2005) in S...
-
Diabetes insipidus is a condition in which the body cannot retain enough water. The patient is excessively thirsty and excretes large am...
-
The word alopecia refers to any type of hair loss , thinning hair or baldness in any hairy region of the body. Baldness tends to be a mo...
-
With over 30 published clinical trials and a 25-year history of helping dieters lose weight and keep it off, Slim-Fast introduces the new ...
-
Ranbaxy Laboratories Limited (Ranbaxy) today announced the launch of its branded product Volix (Voglibose), for the treatment of diabetes....
-
Is Splenda Really As Safe As They Claim It to Be? As of 2005, only six human trials have been conducted on Splenda (sucralose). Of these ...
-
A study revealed that bottled tea contains very low levels of antioxidants and polyphenols compared to brewed tea, a presentation at the ...
No comments:
Post a Comment